Free Trial

Benchmark's Rating of Inflection Point Acquisition Corp. II on 2/27/2025

On February 27, 2025, Benchmark updated its outlook on Inflection Point Acquisition Corp. II (NASDAQ:IPXX) with the action "Upgrade", setting a "Strong-Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Benchmark Co.

DateCompanyAction
9/15/2025
AppLovin Corporation stock logo
APP
AppLovin
Boost Price Target
9/15/2025
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
Boost Price Target
9/15/2025
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
Lower Price Target
9/12/2025
Potbelly Corporation stock logo
PBPB
Potbelly
Downgrade
9/11/2025
Lattice Semiconductor Corporation stock logo
LSCC
Lattice Semiconductor
Boost Price Target
9/10/2025
Aeluma, Inc. stock logo
ALMU
Aeluma
Reiterated Rating
More Ratings From Benchmark Co.